Biologic Therapies gets FDA clearance for bone marrow cannulas — 5 key notes

Spinal Tech

Biologic Therapies received U.S. Food and Drug Administration clearance for the Bio-MAC and Bio-CORE Bone Marrow Cannulas.

Here are five things to know:

 

1. The products are designed for physicians to aspirate bone marrow in their office with just local anesthesia.

 

2. The patient’s marrow is concentrated in a centrifuge to derive the maximum number of regenerative cells and growth factors. Concentrated cells and growth factors are then placed back into the patient.

 

3. The procedures is 30 minutes long and can be used in hospitals or ambulatory surgery centers as well.

 

4. Biologic Therapies also offers the AUTOSPIN centrifuge and convenience kits that can deliver 3 mL to 10 mL from each processing cycle.

 

5. The company is currently expanding its business throughout the United States, Europe, India, China and South Africa.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers